NCT03287791: A trial that was reported late by Actavis Inc.
This trial has reported, although it was 369 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03287791 |
|---|---|
| Title | A Multicenter, Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled Study to Evaluate Safety and Clinical Equivalence of a Generic Azelaic Acid Foam, 15% and the Reference Listed Finacea® (Azelaic Acid) Foam,15% in Patients With Moderate Facial Rosacea |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 19, 2016 |
| Completion date | June 22, 2017 |
| Required reporting date | June 22, 2018, midnight |
| Actual reporting date | June 26, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 369 |